Advanced search
Instruments
| Name | Stock exchange | Average volume | Price | Type | ||
|---|---|---|---|---|---|---|
| JOHNSON & JOHNSON | JNJ | Buenos Aires S.E. +1 Other | 10,259 |
10,700
ARS
 | Stock | |
| JOHNSON & JOHNSON | JNJD | Buenos Aires S.E. | 541 |
10.4
USD
| ||
| JOHNSON & JOHNSON | JNJ | Nyse +17 Other | 8,663,309 |
149.7
USD
| Stock | |
| JOHNSON & JOHNSON | 000943981 | Berne S.E. | - |
135.2
CHF
| ||
| JOHNSON & JOHNSON | JNJ | Deutsche Boerse AG | 1,440 |
138.9
EUR
| ||
| JOHNSON & JOHNSON | JNJ * | Mexican S.E. | 1,749 |
2,516
MXN
| ||
| JOHNSON & JOHNSON | JNJ | Swiss Exchange | - |
136
USD
| ||
| JOHNSON & JOHNSON | JNJ | Frankfurt | 4,770 |
138.4
EUR
| ||
| JOHNSON & JOHNSON | JNJ | Wiener Boerse | 49 |
138.6
EUR
| ||
| JOHNSON & JOHNSON | 0R34 | London S.E. | 1,060 |
149
USD
| ||
| JOHNSON & JOHNSON | JNJ | Börse Stuttgart | 551 |
138.5
EUR
| ||
| JOHNSON & JOHNSON | JNJ | Bolsa De Valores De Colombia | - |
581,460
COP
| ||
| JOHNSON & JOHNSON | JNJ | Lima | - |
144.5
USD
| ||
| JOHNSON & JOHNSON | JNJ | Santiago S.E. | - |
159
USD
| ||
| JOHNSON & JOHNSON | JNJ | BOERSE MUENCHEN | 3,815 |
139
EUR
| ||
| JOHNSON & JOHNSON | 4JNJ | Borsa Italiana | - |
138.2
EUR
| ||
| JOHNSON & JOHNSON | JNJ | Bulgaria S.E. | 3 |
139.1
EUR
| ||
| JOHNSON & JOHNSON | JNJCL | Santiago S.E. | - |
155,930
CLP
| ||
| JOHNSON & JOHNSON | JNJ_KZ | Kazakhstan S.E. | 15 |
149.7
USD
| ||
| JOHNSON & JOHNSON | JNJ | Swiss Exchange | - |
500
CHF
| ||
| JOHNSON & JOHNSON | JNJB34 | Sao Paulo | 8,711 |
51.35
BRL
| Stock | |
| JOHNSON & JOHNSON | JNJ0 | Deutsche Boerse AG +1 Other | - |
13.2
EUR
| Stock | |
| JOHNSON & JOHNSON | JNJ | NEO Exchange | 7,981 |
19.99
CAD
| ||
| JOHNSON CONTROLS INTERNATIONAL PLC | JCI | Nyse +7 Other | 5,986,228 |
65.1
USD
| Stock | |
| JOHNSON CONTROLS INTERNATIONAL PLC | TYIA | Deutsche Boerse AG | - |
60.2
EUR
| ||
| JOHNSON CONTROLS INTERNATIONAL PLC | JCI1 N | Mexican S.E. | 0 |
1,003
MXN
| ||
| JOHNSON CONTROLS INTERNATIONAL PLC | 0Y7S | London S.E. | 24 |
65.1
USD
| ||
| JOHNSON CONTROLS INTERNATIONAL PLC | TYIA | Börse Stuttgart | - |
60.22
EUR
| ||
| JOHNSON CONTROLS INTERNATIONAL PLC | TYIA | BOERSE MUENCHEN | 113 |
60.46
EUR
| ||
| JOHNSON CONTROLS INTERNATIONAL PLC | TYIA | Frankfurt | 22 |
60.48
EUR
| ||
| JOHNSON CONTROLS INTERNATIONAL PLC | TYIA | Berne S.E. | - | - CHF
| ||
| BILL HOLDINGS, INC. | BILL | Nyse +6 Other | 2,059,108 |
55.97
USD
| Stock | |
| BILL HOLDINGS, INC. | 0M5 | Deutsche Boerse AG | - |
52.02
EUR
| ||
| BILL HOLDINGS, INC. | 0M5 | Börse Stuttgart | - |
51.8
EUR
| ||
| BILL HOLDINGS, INC. | 0M5 | BOERSE MUENCHEN | - |
52.55
EUR
| ||
| BILL HOLDINGS, INC. | 0A75 | London S.E. | 63 |
55.97
USD
| ||
| BILL HOLDINGS, INC. | 0M5 | Berne S.E. | - | - CHF
| ||
| BILL HOLDINGS, INC. | BILL1 * | Mexican S.E. | 0 |
1,087
MXN
| ||
| BILL HOLDINGS, INC. | B2HI34 | Sao Paulo | 13,226 |
1.62
BRL
| Stock | |
| JOHNSON PHARMACARE LIMITED | SUNSHINE6 | Bombay S.E. | 1,017,581 |
0.87
INR
| Stock | |
| JOHNSON OUTDOORS INC. | JOUT | Nasdaq | 58,848 |
37.88
USD
| Stock | |
| PRISM JOHNSON LIMITED | PRSMJOHNSN | Bombay S.E. +1 Other | 21,483 |
154
INR
| Stock | |
| PRISM JOHNSON LIMITED | PRSMJOHNSN | NSE India S.E. | 214,696 |
154
INR
|
News (12663)
Companies (460)
Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows: - pharmaceutical products (55.4%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, ...
Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows: - pharmaceutical products (55.4%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, ...
Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows: - pharmaceutical products (55.4%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, ...
Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows: - pharmaceutical products (55.4%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, ...
Royalty Pharma plc is a buyer of biopharmaceutical royalties and a funder of innovation across the biopharmaceutical industry. The Company collaborates with innovators from academic institutions, research hospitals and non-profits through small and mid-ca ...
Allegion plc specializes in manufacturing and marketing security systems. Products are sold under the Cisa, Interflex, LCN, Schlage, Von Duprin, Aptiq, Bocom, Briton, Bricard, Dexter, Falcon, Glynn-Johnson, Ito Kilit, Ives, Kryptonite, Legge, Normbau, Ste ...
Turkiye Garanti Bankasi AS is a Turkey-based banking institution. It operates under the following business segments: Retail Banking, Corporate/Commercial Banking and Investment Banking. The banking products served to customers are: custody services, time ...
Kenvue Inc. is one of the world leaders in the design, manufacture and marketing of consumer healthcare products. The group offers products for health, beauty, baby care, oral care, skin care and more. The business is organized around 3 product families: ...
CTBC FINANCIAL HOLDING CO., LTD. is a Taiwan-based financial holding company. The Company is principally engaged in investment banking business, bills finance business, credit card business, trust business, insurance business, securities business, futures ...
CTBC FINANCIAL HOLDING CO., LTD. is a Taiwan-based financial holding company. The Company is principally engaged in investment banking business, bills finance business, credit card business, trust business, insurance business, securities business, futures ...
Insiders
Bill Johnson, CPA joined Flagship Pioneering in 2017 as director of finance.
He became vice president of finance in 2018.
In this role, Bill works with the Fund Operations team focusing on financial reporting, deal modeling, and technology implementation.
Bill received his CPA license while working at PricewaterhouseCoopers in Boston, and then began his career in Venture Capital and Private Equity first with Summit Partners, then moving to Kodiak Venture Partners and Cue Ball Capital.
Most recently, prior to joining Flagship, Bill served as CFO for a number of life science companies, including Allegro Diagnostics, which was acquired by Veracyte, Lumicell and GreenLight Biosciences.
Bill holds a B.A in economics and accounting from the College of the Holy Cross, and an M.B.A from Boston College.
Bill C.
Johnson worked as a Chief Financial Officer at XCEND Group, Inc. and as a Financial Analyst at Growth Management Solutions, Inc. He received an undergraduate degree from Alma College in 2003 and an MBA from Northwood University (Michigan) in 2004.
Bill Johnson currently works as a Director of Information Services at Pine Rest Christian Mental Health Services.
Bill Johnson currently works as a Treasurer & Trustee at Rolling Hills Preparatory School.
No results for this search
- Stock Market
- Advanced search
- Bill Johnson